26
Participants
Start Date
June 30, 2012
Primary Completion Date
September 30, 2015
Study Completion Date
July 31, 2017
Dexanabinol
"Dexanabinol: intravenous infusion over 3 hours, weekly (i.e., Day 1, 8, 15 and 22 of a 28-day cycle)~Nine dosing cohorts are planned, with the option to enroll additional cohorts based on safety and PK data.~Dose Level 1: 2 mg/kg~Dose Level 2: 4 mg/kg~Dose Level 3: 8 mg/kg~Dose Level 4: 16 mg/kg~Dose Level 5: 24 mg/kg~Dose Level 6: 28 mg/kg~Dose Level 7: 36 mg/kg~Dose Level 8: 40 mg/kg~Dose Level 9: 44 mg/kg"
Moores UCSD Cancer Center, La Jolla
e-Therapeutics PLC
INDUSTRY
Santosh Kesari, M.D., Ph.D.
OTHER